Stay updated on Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:09.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-25T20:10:46.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision history updated to add v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:13:25.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 entry was added to the record history, and a lengthy government funding status notice was removed from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T09:18:15.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status, and updated the record history to Revision: v3.4.1 while removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T05:15:07.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    UI enhancements include a glossary display option, color-coded change indicators, and an updated revision label.
    Difference
    1%
    Check dated 2026-01-28T02:40:45.000Z thumbnail image

Stay in the know with updates to Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.